Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Dec;22(6):1026–1030. doi: 10.1128/aac.22.6.1026

Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.

K O Smith, K S Galloway, K K Ogilvie, U O Cheriyan
PMCID: PMC185715  PMID: 6297382

Abstract

9-[[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine (BIOLF-62) is highly synergistic with either phosphonoformate or phosphonoacetate when used in combination against herpes simplex virus types 1 and 2 in vitro. Acycloguanosine did not show significant synergism with these two compounds. Bromovinyldeoxyuridine and phosphonoformate were highly synergistic against herpes simplex virus type 2, but not against type 1.

Full text

PDF
1026

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayisi N. K., Gupta V. S., Meldrum J. B., Taneja A. K., Babiuk L. A. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother. 1980 Apr;17(4):558–566. doi: 10.1128/aac.17.4.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Champney K. J., Lauter C. B., Bailey E. J., Lerner A. M. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. J Clin Invest. 1978 Dec;62(6):1142–1153. doi: 10.1172/JCI109233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cho C. T., Feng K. K., Brahmacupta N. Synergistic antiviral effects of adenine arabinoside and humoral antibodies in experimental encephalitis due to Herpesvirus hominis. J Infect Dis. 1976 Feb;133(2):157–167. doi: 10.1093/infdis/133.2.157. [DOI] [PubMed] [Google Scholar]
  4. Chow A. W. Genital infection with type 2 herpes simplex virus. A common venereal disease. Postgrad Med. 1975 Aug;58(2):66–70. doi: 10.1080/00325481.1975.11714121. [DOI] [PubMed] [Google Scholar]
  5. Darby G., Field H. J., Salisbury S. A. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature. 1981 Jan 1;289(5793):81–83. doi: 10.1038/289081a0. [DOI] [PubMed] [Google Scholar]
  6. De Clercq E., Descamps J., De Somer P., Barr P. J., Jones A. S., Walker R. T. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2947–2951. doi: 10.1073/pnas.76.6.2947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Clercq E., Descamps J., Huang G. F., Torrence P. F. 5-Nitro-2'-deoxyuridine and 5-nitro-2'-deoxyuridine 5'-monophosphate: antiviral activity and inhibition of thymidylate synthetase in vivo. Mol Pharmacol. 1978 May;14(3):422–430. [PubMed] [Google Scholar]
  8. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eriksson B., Oberg B. Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate. Antimicrob Agents Chemother. 1979 Jun;15(6):758–762. doi: 10.1128/aac.15.6.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fischer P. H., Lee J. J., Chen M. S., Lin T. S., Prusoff W. H. Synergistic effect of 5'-amino-5'-deoxythymidine and 5-iodo-2'-deoxyuridine against Herpes Simplex virus infections in vitro. Biochem Pharmacol. 1979 Dec 1;28(23):3483–3486. doi: 10.1016/0006-2952(79)90092-3. [DOI] [PubMed] [Google Scholar]
  11. HERRMAN E. C., Jr Plaque inhibition test for detection of specific inhibitors of DNA containing viruses. Proc Soc Exp Biol Med. 1961 May;107:142–145. [PubMed] [Google Scholar]
  12. Kern E. R., Richards J. T., Overall J. C., Jr, Glasgow L. A. Genital Herpesvirus homonis infection in mice. II. Treatment with phosphonoacetic acid, adenine arabinoside, and adenine arabinoside 5'-monophosphate. J Infect Dis. 1977 Apr;135(4):557–567. doi: 10.1093/infdis/135.4.557. [DOI] [PubMed] [Google Scholar]
  13. Lefkowitz E., Worthington M., Conliffe M. A., Baron S. Comparative effectiveness of six antiviral agents in Herpes simplex type 1 infection of mice. Proc Soc Exp Biol Med. 1976 Jul;152(3):337–342. doi: 10.3181/00379727-152-39392. [DOI] [PubMed] [Google Scholar]
  14. Lerner A. M., Bailey E. J. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. J Infect Dis. 1976 Oct;134(4):400–404. doi: 10.1093/infdis/134.4.400. [DOI] [PubMed] [Google Scholar]
  15. ROIZMAN B., ROANE P. R., Jr A physical difference between two strains of herpes simplex virus apparent on sedimentation in cesium chloride. Virology. 1961 Sep;15:75–79. doi: 10.1016/0042-6822(61)90079-4. [DOI] [PubMed] [Google Scholar]
  16. Reno J. M., Lee L. F., Boezi J. A. Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate. Antimicrob Agents Chemother. 1978 Feb;13(2):188–192. doi: 10.1128/aac.13.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SMITH K. O. SOME BIOLOGIC ASPECTS OF HERPESVIRUS-CELL INTERACTIONS IN THE PRESENCE OF 5-IODO, 2-DESOXYURIDINE (IDU). DEMONSTRATION OF A CYTOTOXIC EFFECT BY HERPESVIRUS. J Immunol. 1963 Nov;91:582–590. [PubMed] [Google Scholar]
  18. Shannon W. M., Arnett G., Schabel F. M., Jr, North T. W., Cohen S. S. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice. Antimicrob Agents Chemother. 1980 Oct;18(4):598–603. doi: 10.1128/aac.18.4.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shannon W. M. Introductory remarks on adenine arabinoside. Ann N Y Acad Sci. 1977 Mar 4;284:3–5. doi: 10.1111/j.1749-6632.1977.tb21930.x. [DOI] [PubMed] [Google Scholar]
  20. Shipkowitz N. L., Bower R. R., Appell R. N., Nordeen C. W., Overby L. R., Roderick W. R., Schleicher J. B., Von Esch A. M. Suppression of herpes simplex virus infection by phosphonoacetic acid. Appl Microbiol. 1973 Sep;26(3):264–267. doi: 10.1128/am.26.3.264-267.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Smith K. O., Galloway K. S., Kennell W. L., Ogilvie K. K., Radatus B. K. A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother. 1982 Jul;22(1):55–61. doi: 10.1128/aac.22.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith K. O., Kennell W. L., Poirier R. H., Lynd F. T. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). Antimicrob Agents Chemother. 1980 Feb;17(2):144–150. doi: 10.1128/aac.17.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stanwick T. L., Schinazi R. F., Campbell D. E., Nahmias A. J. Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2. Antimicrob Agents Chemother. 1981 Apr;19(4):672–674. doi: 10.1128/aac.19.4.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. VANTSIS J. T., WILDY P. Interaction of herpes virus and HeLa cells: comparison of cell killing and infective center formation. Virology. 1962 Jun;17:225–232. doi: 10.1016/0042-6822(62)90112-5. [DOI] [PubMed] [Google Scholar]
  25. Wellings P. C., Awdry P. N., Bors F. H., Jones B. R., Brown D. C., Kaufman H. E. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol. 1972 Jun;73(6):932–942. doi: 10.1016/0002-9394(72)90463-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES